149 related articles for article (PubMed ID: 38033560)
1. Host cell-based screening assays for identification of molecules targeting
Hu Y; Webb JS; An SQ
Front Microbiol; 2023; 14():1279922. PubMed ID: 38033560
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa.
Rugjee KN; An SQ; Ryan RP
J Vis Exp; 2016 Jun; (112):. PubMed ID: 27404278
[TBL] [Abstract][Full Text] [Related]
3. Putrescine and Its Metabolic Precursor Arginine Promote Biofilm and c-di-GMP Synthesis in Pseudomonas aeruginosa.
Liu Z; Hossain SS; Morales Moreira Z; Haney CH
J Bacteriol; 2022 Jan; 204(1):e0029721. PubMed ID: 34723645
[TBL] [Abstract][Full Text] [Related]
4. Cyclic Di-GMP Signaling Contributes to Pseudomonas aeruginosa-Mediated Catheter-Associated Urinary Tract Infection.
Cole SJ; Lee VT
J Bacteriol; 2016 Jan; 198(1):91-7. PubMed ID: 26195591
[TBL] [Abstract][Full Text] [Related]
5. Glucose-6-Phosphate Acts as an Extracellular Signal of SagS To Modulate
Park S; Dingemans J; Gowett M; Sauer K
mSphere; 2021 Feb; 6(1):. PubMed ID: 33568456
[TBL] [Abstract][Full Text] [Related]
6. Light-Mediated Decreases in Cyclic di-GMP Levels Inhibit Structure Formation in
Kahl LJ; Price-Whelan A; Dietrich LEP
J Bacteriol; 2020 Jun; 202(14):. PubMed ID: 32366589
[TBL] [Abstract][Full Text] [Related]
7. The anti-cancerous drug doxorubicin decreases the c-di-GMP content in Pseudomonas aeruginosa but promotes biofilm formation.
Groizeleau J; Rybtke M; Andersen JB; Berthelsen J; Liu Y; Yang L; Nielsen TE; Kaever V; Givskov M; Tolker-Nielsen T
Microbiology (Reading); 2016 Oct; 162(10):1797-1807. PubMed ID: 27526691
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-based reporter for gauging cyclic di-GMP levels in Pseudomonas aeruginosa.
Rybtke MT; Borlee BR; Murakami K; Irie Y; Hentzer M; Nielsen TE; Givskov M; Parsek MR; Tolker-Nielsen T
Appl Environ Microbiol; 2012 Aug; 78(15):5060-9. PubMed ID: 22582064
[TBL] [Abstract][Full Text] [Related]
9. The Nitrite Transporter Facilitates Biofilm Formation via Suppression of Nitrite Reductase and Is a New Antibiofilm Target in Pseudomonas aeruginosa.
Park JS; Choi HY; Kim WG
mBio; 2020 Jul; 11(4):. PubMed ID: 32636243
[TBL] [Abstract][Full Text] [Related]
10. Identification of small molecules that interfere with c-di-GMP signaling and induce dispersal of Pseudomonas aeruginosa biofilms.
Andersen JB; Hultqvist LD; Jansen CU; Jakobsen TH; Nilsson M; Rybtke M; Uhd J; Fritz BG; Seifert R; Berthelsen J; Nielsen TE; Qvortrup K; Givskov M; Tolker-Nielsen T
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):59. PubMed ID: 34244523
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of
Zheng Y; Tsuji G; Opoku-Temeng C; Sintim HO
Chem Sci; 2016 Sep; 7(9):6238-6244. PubMed ID: 30034764
[TBL] [Abstract][Full Text] [Related]
12. Manganese Acts as an Environmental Inhibitor of Pseudomonas aeruginosa Biofilm Development by Inducing Dispersion and Modulating c-di-GMP and Exopolysaccharide Production via RbdA.
Park S; Dingemans J; Sauer K
J Bacteriol; 2023 Jun; 205(6):e0000323. PubMed ID: 37199658
[TBL] [Abstract][Full Text] [Related]
13. Insulin treatment enhances pseudomonas aeruginosa biofilm formation by increasing intracellular cyclic di-GMP levels, leading to chronic wound infection and delayed wound healing.
Wei Q; Zhang Z; Luo J; Kong J; Ding Y; Chen Y; Wang K
Am J Transl Res; 2019; 11(6):3261-3279. PubMed ID: 31312343
[TBL] [Abstract][Full Text] [Related]
14. The Cyclic AMP-Vfr Signaling Pathway in Pseudomonas aeruginosa Is Inhibited by Cyclic Di-GMP.
Almblad H; Harrison JJ; Rybtke M; Groizeleau J; Givskov M; Parsek MR; Tolker-Nielsen T
J Bacteriol; 2015 Jul; 197(13):2190-200. PubMed ID: 25897033
[TBL] [Abstract][Full Text] [Related]
15. Elevated c-di-GMP Levels and Expression of the Type III Secretion System Promote Corneal Infection by Pseudomonas aeruginosa.
Yam JKH; Aung TT; Chua SL; Cheng Y; Kohli GS; Zhou J; Constancias F; Liu Y; Cai Z; Salido MMS; Drautz-Moses DI; Rice SA; Schuster SC; Boo ZZ; Wu B; Kjelleberg S; Tolker-Nielsen T; Lakshminarayanan R; Beuerman RW; Yang L; Givskov M
Infect Immun; 2022 Aug; 90(8):e0006122. PubMed ID: 35913171
[TBL] [Abstract][Full Text] [Related]
16. Genetic Tools to Study c-di-GMP-Dependent Signaling in Pseudomonas aeruginosa.
Leoni L; Pawar SV; Rampioni G
Methods Mol Biol; 2017; 1657():471-480. PubMed ID: 28889314
[TBL] [Abstract][Full Text] [Related]
17. A Library of Promoter-
Liu D; Wang D; Wei Q; Zhang Y; Yu H; Ma LZ
Appl Environ Microbiol; 2023 Feb; 89(2):e0189122. PubMed ID: 36744921
[TBL] [Abstract][Full Text] [Related]
18. Molecular and structural facets of c-di-GMP signalling associated with biofilm formation in Pseudomonas aeruginosa.
Banerjee P; Sahoo PK; Sheenu ; Adhikary A; Ruhal R; Jain D
Mol Aspects Med; 2021 Oct; 81():101001. PubMed ID: 34311995
[TBL] [Abstract][Full Text] [Related]
19. Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa.
Hwang HJ; Choi H; Hong S; Moon HR; Lee JH
Microbiol Spectr; 2021 Oct; 9(2):e0024921. PubMed ID: 34494853
[TBL] [Abstract][Full Text] [Related]
20. Genome characterization of a uropathogenic
Lin S; Chen S; Li L; Cao H; Li T; Hu M; Liao L; Zhang LH; Xu Z
Front Cell Infect Microbiol; 2022; 12():956445. PubMed ID: 36004331
[No Abstract] [Full Text] [Related]
[Next] [New Search]
